Michael Smith
Health editor at the Financial Review, providing expertise on CSL's history, operations and recent investor and regulatory challenges discussed in the episode.
Best podcasts with Michael Smith
Ranked by the Snipd community
10 snips
Nov 5, 2025 • 24min
The biggest Australian company you've never heard of (and why it's in trouble)
Michael Smith, health editor at the Financial Review, dives into CSL, Australia's biotech giant. He traces CSL's rise from a government lab to a $145 billion player, discussing its core products like plasma therapies and vaccines. Smith highlights the struggles post-Vifor acquisition, investor distrust, and the fallout from declining US vaccination rates. He also touches on political issues, including Trump-era tariffs impacting CSL's future. Can CSL regain investor confidence? Smith offers insights into the company's potential recovery.
Apr 9, 2025 • 27min
The fight to save Australia's private hospitals
Michael Smith, Health editor at the Australian Financial Review, discusses the looming crisis facing Healthscope, Australia’s second-largest private hospital operator. He highlights the complex battle between health insurers and private hospitals, exploring the financial struggles exacerbated by the pandemic. Smith addresses how private equity could disrupt healthcare infrastructure and the implications of potential ownership changes. With urgent calls for government intervention, he underscores the need for a balanced approach to sustain both public and private healthcare sectors.
